Ou D, Mitchell L A, Décarie D, Tingle A J, Lacroix M, Zrein M
Department of Paediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Viral Immunol. 1998;11(2):93-102. doi: 10.1089/vim.1998.11.93.
The influence of single amino acid substitutions within a rubella E1 protein T-cell epitope, E1(273-284) on T-cell recognition was studied. Substitutions of an uncharged amino acid A for an E or for a T and substitution of a T for S were found to not significantly reduce the T-cell responses. However, substitution of a charged residue such as E for hydrophobic residues (I, V, or W); D for Q; or a relatively larger size amino acid for polar residues completely abolished the cytotoxicities mediated by E1(273-284)-specific T-cell clone. A set of single amino acid-substituted peptide analogs of E1(273-284) not eliciting cytotoxicity of the T-cell clone was used to test the influence of point mutation of the epitope on HLA DR restrictions. A panel of B-cell lines with different DR4 subtypes was used as targets in cytotoxicity assays to determine the restrictive HLA molecules. Results showed that modification of the T-cell epitope by point mutation could reverse the HLA DR restriction from one allele to other alleles. A model based on these results has been proposed to explain the mechanism balancing major histocompatibility complex (MHC) polymorphism in outbred populations.
研究了风疹E1蛋白T细胞表位E1(273 - 284)内单个氨基酸取代对T细胞识别的影响。发现用不带电荷的氨基酸A取代E或T以及用T取代S不会显著降低T细胞反应。然而,用带电荷的残基如E取代疏水残基(I、V或W);用D取代Q;或用相对较大的氨基酸取代极性残基,完全消除了E1(273 - 284)特异性T细胞克隆介导的细胞毒性。一组不引起T细胞克隆细胞毒性的E1(273 - 284)单氨基酸取代肽类似物用于测试表位点突变对HLA DR限制的影响。在细胞毒性试验中,使用一组具有不同DR4亚型的B细胞系作为靶标来确定限制性HLA分子。结果表明,通过点突变修饰T细胞表位可使HLA DR限制从一个等位基因反转至其他等位基因。基于这些结果提出了一个模型来解释平衡远交群体中主要组织相容性复合体(MHC)多态性的机制。